Wenbin Qian
- Hematology top 2%
- Acute Myeloid Leukemia Research 37
- Multiple Myeloma Research and Treatments 18
- Chronic Myeloid Leukemia Treatments 17
- Oncology top 2%
- CAR-T cell therapy research 45
- Immunology top 5%
- Immune Cell Function and Interaction 17
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes 17
- Genetics top 5%
- Virus-based gene therapy research 22
-
- Lymphoma Diagnosis and Treatment 21
- Cited by
- HematologyOncologyImmunology
- Journals
- Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (1 paper)The Journal of Cell Biology (1 paper)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Wenbin Qian
162 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 112
- Hematology 616
- Oncology 997
- Immunology 585
- Molecular Biology 1.4k
- Genetics 199
Countries citing papers authored by Wenbin Qian
This map shows the geographic impact of Wenbin Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Qian more than expected).
Fields of papers citing papers by Wenbin Qian
This network shows the impact of papers produced by Wenbin Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Qian. The network helps show where Wenbin Qian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenbin Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 14 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 23 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 16 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 19 | |
| 12 | 2023 | 6 | |
| 13 | 2022 | 16 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 104 | |
| 17 | 2019 | 21 | |
| 18 | 2019 | 11 | |
| 19 | 2014 | 7 | |
| 20 | 2009 | 20 |
About Wenbin Qian
Wenbin Qian is a scholar working on Hematology, Oncology and Immunology, having authored 170 papers that have together received 2.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (45 papers), Acute Myeloid Leukemia Research (37 papers), Virus-based gene therapy research (22 papers), Lymphoma Diagnosis and Treatment (21 papers), Multiple Myeloma Research and Treatments (18 papers), Retinoids in leukemia and cellular processes (17 papers), Immune Cell Function and Interaction (17 papers) and Chronic Myeloid Leukemia Treatments (17 papers). The work is most often cited by research in Hematology (616 citations), Oncology (997 citations) and Immunology (585 citations). Wenbin Qian has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Jie Jin, Liangshun You, Haitao Meng, Xianbo Huang, Wanmao Ni, Wen Lei, Weilai Xu, Xiujin Ye, Junqing Liu and Hongyan Tong. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.